Louis Lacombe

A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferationpublié le 2024-03-22

Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Studypublié le 2023-04-09

Effects of Concentrated Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplementation on Quality of Life after Radical Prostatectomy: A Phase II Randomized Placebo-Controlled Trial (RCT-EPA)publié le 2023-03-11

Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancerpublié le 2023-01-19

Effects of omega-3 fatty acids supplementation on perioperative blood loss and complications after radical prostatectomypublié le 2022-02

Follicle-stimulating hormone (FSH) levels prior to prostatectomy are not related to long-term oncologic or cardiovascular outcomes for men with prostate cancer.publié le 2022-01

Double inferior vena cava systems during retroperitoneal surgery: Description of a systematic approach to a rare and challenging anatomic variant.publié le 2021-12

Résumés AUQ 2021.publié le 2021-11

¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is accurate for high-grade prostate cancer bone staging when compared to bone scintigraphy.publié le 2021-10

Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Full-text.publié le 2021-08

Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Abridged version.publié le 2021-08

Urinary oestrogen steroidome as an indicator of the risk of localised prostate cancer progressionpublié le 2021-07-06